Cocito, D., Peci, E., Lauria Pinter, G., Dacci, P., Di Muzio, A., Telese, R., Schenone, A., Benedetti, L., Antonini, G., Morino, S., Sorbi, S., Matà, S., Bril, V., van Geloven, N., Hartung, H., Lewis, R., Sobue, G., Lawo, J., Mielke, O., Durn, B., Cornblath, D., Merkies, I., van Schaik, I., & , (n.d.). feasibility of switching from intravenous to subcutaneous immunoglobulin in CIDP: PATH trial and clinical experience. Clinical neurophysiology, 130(1), e12–. http://access.bl.uk/ark:/81055/vdc_100074897021.0x00000f